Corporate Governance25 Sept 2026, 03:36 pm
Vivo Bio Tech Closes Trading Window for Q2 FY27
AI Summary
Vivo Bio Tech Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut for all insiders, including designated persons and their immediate relatives, from October 01, 2026, until 48 hours after the declaration of the Unaudited Standalone and Consolidated Financial Results for the second quarter ended September 30, 2026.
Key Highlights
- Trading window closed for Q2 FY27 results announcement.
- Closure effective from October 01, 2026.
- Applies to all insiders and designated persons.
- In compliance with SEBI insider trading regulations.
Price Impact
More from VIVOBIOT